Open Access826Health Economic Outcome Analysis of patients randomized in the SECURE Phase III Trial comparing Isavuconazole to Voriconazole for primary treatment of Invasive fungal disease caused by Aspergillus Species or other filamentous Fungi
Author(s) -
Nikhil Khandelwal,
Billy Franks,
Fei Shi,
James Spalding,
Nkechi Azie
Publication year - 2014
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofu052.534
Subject(s) - voriconazole , medicine , aspergillus , fungal disease , randomized controlled trial , microbiology and biotechnology , biology , antifungal , dermatology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom